Table 3 RASSF1A methylation index in hepatocellular adenoma (HA), focal nodular hyperplasia (FNH) and corresponding non-lesional liver (NLL) with viable multiple samplings. Each dot refers to RASSF1A methylation index (%) in one sampling. In brackets: number of tissue samples analyzed in each group of lesions.
From: Quantitative evaluation of RASSF1Amethylation in the non-lesional, regenerative and neoplastic liver
Patient | Age | HA (n = 13) | FNH(n = 22) | NLL(n = 34) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
43 | 26 |
|
| |||||||||||
39 | 28 |
|
|
| ○ | ○ | ○ | ○ | ||||||
40 | 30 |
| ○ | |||||||||||
46 | 33 |
|
| |||||||||||
44 | 33 |
|
|
|
| ○ |
| ○ | ○ | ○ | ||||
49 | 34 | ● | ● |
| ○ | ○ | ||||||||
48 | 36 |
| ○ | |||||||||||
50 | 38 |
|
|
|
|
|
|
|
| |||||
41 | 39 |
| ○ | ○ | ○ |
| ○ | ○ | ○ | |||||
51 | 40 | ● | ● | |||||||||||
47 | 44 | ● | ● | ● | ● |
|
| ○ | ||||||
42 | 47 | ● |
|
|
|
|
|
| ||||||
45 | 54 | ● | ● |
|
| ● |
|
|
| |||||
- ○ = RASSF1A methylation index: <10%
-
= RASSF1A methylation index: 10–50% - ● = RASSF1A methylation index: >50%